Answers are grounded in this paper and cite their sources.
Comparative cohort study assesses psychological impact of COVID-19 on infertile and fertile women, suggesting need for ongoing mental health support.
OBJECTIVE: To assess the impact of the COVID-19 pandemic on symptoms of anxiety, depression, and stress among infertile and fertile women. METHODS: This prospective cohort study evaluated psychological distress using the 42-item Depression, Anxiety and Stress Scale (DASS-42) at two time points: during the early pandemic (Phase 1) and after six months (Phase 2). The study included infertile women whose embryo transfers were postponed (n=71) and fertile women who had given birth over six months earlier without fertility issues (n=117). Ethical approval was obtained (CAAE: 32964620.3.1001.5334). RESULTS: The mean age was higher in the infertile group (37.8 vs. 35.5 years; p=0.001). In Phase 1, infertile women reported significantly higher levels of stress (7.7 vs. 5.6; p=0.018) and depression (4.0 vs. 2.3; p=0.002), with no significant difference in anxiety (3.4 vs. 2.7; p=0.389). In Phase 2, stress (3.7 vs. 3.1; p=0.201), depression (4.0 vs. 3.5; p=0.446), and anxiety (5.8 vs. 5.4; p=0.666) scores were similar between groups. Longitudinal analysis in both infertile and fertile groups showed a significant reduction in stress and an increase in anxiety. Depressive symptoms worsened in the fertile group (p=0.018). CONCLUSION: Infertile women initially showed higher stress and depression than fertile controls. Over six months, stress declined and anxiety increased in both groups; depressive symptoms remained stable in infertile women but slightly worsened among fertile women. These findings support the inclusion of targeted and ongoing mental health support as part of fertility care.
No takes yet. Share an insight, caveat, or question.
Lorenzzoni et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: